Possible Association of Maternal Haemorrhoid with Congenital Abnormalities in their Children - a Population-Based Case-Control Study
Objectives: To look for a possible association of maternal haemorrhoid during pregnancy with a risk of congenital abnormalities in their children.
Methods: Comparison of the prevalence of medically-recorded haemorrhoid in pregnant women who had fetuses/newborns (cases) with congenital abnormalities and healthy babies (controls) in the population-based Hungarian Case-Control Surveillance System of Congenital Abnormalities.
Results: Of 22,843 cases with congenital abnormalities, 798 (3.49%), while of 38,151 controls, 1,624 (4.26%) had mothers with recorded and usually treated severe haemorrhoids. We found a higher risk for exomphalos (OR with 95% CI: 4.9, 1.7-7.9), and malposition-malrotation of gut (OR with 95% CI: 17.2, 2.1-142.0) which were present in 14 and 8 children of pregnant women with haemorrhoid, respectively. These associations could not be explained by teratogenic effect of maternal haemorrhoid or by drug treatments, so we hypothesized a possible common genetic background.
Conclusions: The higher frequency of exomphalos and malposition-malrotation of gut found in the children of mothers with haemorrhoid during pregnancy requires further study.
Weakley FL. Anal and perinatal lesions. In: Farmer RG, Achkar E, Fleshler B. Clinical Gastroenterology. Raven Press, New York, 1983; pp.401-407.
Swiet RL, de (ed.). Medical Disorders in Obstetric Practice. 4th, Blackwell, Oxford 2002.
Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55:299-305.
Czeizel AE, Intody Zs, Modell B. What proportion of congenital abnormalities can be prevented? Brit Med J 1993; 306:499-503.
Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003; 12:409-416.
Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004;191:790-794
Puho E, Métneki J, Czeizel AE. Maternal employment status and isolated orofacial clefts in Hungary. Cent Eur J Publ Health 2005; 13:144-148.
Czeizel AE, Puho HE, Ács N, Bánhidy F. Use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res Part A 2008; 82:139-146.
Shaffer JP. Multiple hypothesis testing. Ann Rev Psych 1995; 46:561-584.
Ledbetter DJ. Gastroschisis and omphalocele. Surg Clin North Am 2006; 86:249-260.
Jones KL. Smith's Recognizable Patterns of Human Malformations. 4th ed. W. B. Saunders Company, Philadelphia, 1988.
Czeizel AE, Vitéz M. Etiological study of omphalocele. Hum Genet 1981; 58:390-395.
Osuna A, Lindham S. Four cases of omphalocele on two generation of the same family. Clin Genet 1976; 9:354-356.
Czeizel AE. Recurrence risk of omphalocele. Lancet 1979; 314(8140):470.
Kanagawa SL, Begleiter ML, Ostlie DJ. Omphalocele in three generations with autosomal dominant transmission J Med Genet 2002; 39:184-185.
Carmi R, Abeliovich D, Siplovich L. Familial midgut anomalies - a spectrum of defects due to the same cause? Am J Med Genet 1981; 8:443-446.
Stalker HJ, Chitayat D. Familial intestinal malrotation with midgut volvulus and facial anomalies: a disorder involving a gene controlling the normal gut rotation? Am J Med Genet 1992; 44:46-47.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th edition, Lippincot Williams and Wilkins, Philadelphia, 2005.
Czeizel AE, Rockenbauer M. The evaluation of drotaverine intake during pregnancy on fetal development. Prenat Neonat Med 1996; 1:137-146.
Bánhidy F, Ács N, Puhó HE, Czeizel AE. A population-based case-control teratologic study of oral dipyrone treatment during pregnancy. Drug Safety 2006; 46:39-42.
Czeizel AE, Rockenbauer M, Mosonyi A. A population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy. Pharmacoepid Drug Safety 2000; 9:193-205.
Norgard B, Puho E, Czeizel AE, Skriver MV, Soensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study. Am J Obstet Gynecol 2005; 152:922-923.
Ács N, Bánhidy F, Puho HE, Czeizel AE. Senna treatment in pregnant women and congenital abnormalities in their offspring. - A population-based case-control study. Reprod Toxic 2009; 28:100-104.
Czeizel AE, Tóth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology 1999; 10:437-440.
Czeizel AE. Periconceptional multivitamin supplementation and nonneural midline defects. Am J Med Genet 1993; 46:611.
Botto LD, Mulinare J, Erickson JD. Occurrence of omphalocele in relation to maternal multivitamin use: a population-based study. Pediatrics 2002; 109:904-908.
Watkins ML. Maternal obesity and risk for birth defects. Pediatrics 2003; 111:1152-1158.
Waller DK. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 2007; 16:745-750.